An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase

HIGHLIGHTS

• who: Juan Luis Steegmann from the Hematologia, Universidad de Cantabria, Santander, Spain have published the Article: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase, in the Journal: (JOURNAL)
• what: Purpose This study was aimed to analyze the association of very early molecular response to with the achievement of deep molecular response (MR4) at months. Given the scarcity and heterogeneity of the data on the kinetics of the descent of BCR-ABL1IS in patients treated with nilotinib upfront . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.